Epilepsy trials in Finland
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Where
- Kuopio
- Age
- 18 years and over
- People
- 360 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00 - Phase 3Enrolling by invitationAn Open-label Study of XEN1101 in Epilepsy
- Where
- Kuopio
- Age
- 12 years and over
- People
- 880 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00 - No phaseTaking peopleProspective Natural History Study of POLG Disease
- Where
- Helsinki
- People
- 300 worldwide
- Run by
- The POLG Foundation
See details and how to joinNCT07775872 - Phase 2Enrolling by invitationLong-term Safety and Tolerability of BHV-7000
- Where
- Helsinki, Kuopio, Tampere
- Age
- 18 years to 75 years
- People
- 660 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00